Author ORCID Identifier

https://orcid.org/0000-0003-4042-4716

Date of Graduation

5-2020

Document Type

Dissertation (PhD)

Program Affiliation

Biochemistry and Molecular Biology

Degree Name

Doctor of Philosophy (PhD)

Advisor/Committee Chair

Michael R. Blackburn, Ph.D.

Committee Member

Holger Eltzschig, M.D., Ph.D.

Committee Member

Scott E. Evans, M.D.

Committee Member

Leng Han, Ph.D.

Committee Member

Harry Karmouty-Quintana, Ph.D.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease which affects about 5 to 8 million individuals in the world. Despite the high prevalence, there is currently no cure for IPF, and the cause of this disease is still unclear. Our laboratory and collaborators have shown that nudix hydrolase 21 (NUDT21, which is also known as cleavage factor 25, CFIm25) is a key regulator of alternative polyadenylation (APA). NUDT21 depletion causes 3’UTR shortening via APA leading to enhanced mRNA stability and protein translation. This NUDT21 reduction promotes tumor growth in glioblastoma by enhancing expression of oncogenes. Cancer and IPF share cellular features, such as enhanced expression for pathological mediators and increased cell proliferation. However, whether APA plays a role in lung fibrosis is not known. Our results reveal that NUDT21 reduction is found in lung fibroblasts isolated from IPF patients. Depletion of NUDT21 causes 3’UTR shortening in pro-fibrotic genes, such as Wnt and TGFb1, leading to robust protein expression of the pathological genes and ultimately worsening of pulmonary fibrosis. Additionally, we found that TGFb1 depletes NUDT21 in fibroblasts by transcriptionally inducing miR203 through Smad3. Modulating NUDT21 by overexpression or antagomiR203 attenuated NUDT21 reduction-mediated fibrosis in vitro. The results of this dissertation are significant in that these findings broaden our understanding on the role of APA in fibrosis. The knowledge discovered in this project is potentially beneficial as these results may lead to identification of targets for novel therapies which can halt the progression of IPF.

Keywords

polyadenylation, pulmonary fibrosis, transforming growth factor β (TGFβ), mRNA, post-transcriptional regulation, alternative polyadenylation, APA, miR203, NUDT21

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.